What type of study is this?

This is a Systematic Review study (also classified as: Meta-Analysis).

September 10, 2025

Biologic Agents in the Treatment of Severe Chronic Rhinosinusitis with Nasal Polyps in Adults: A Systematic Review and Meta-Analysis

View Full Paper

Ask AI

Bookmark

Authors

MZMengmeng ZhengWenzhou Medical University WHWenjuan HaoNingbo Medical Center Lihuili Hospital QMQingchao MengChinese Academy of Medical Sciences & Peking Union Medical College

Discussion

Member takes

Implication

Systematic review evaluates the efficacy of biologic therapies for chronic rhinosinusitis with nasal polyps, indicating Dupilumab and Tezepelumab are most effective.

Key Points

All biologic therapies reduced nasal polyp burden and improved patient-reported outcomes in chronic rhinosinusitis.
Dupilumab was found to significantly lower the Nasal Polyp Score by 2.4 points and the SNOT-22 score by 19.2 points.
The analysis included eight randomized controlled trials with a total of 2,564 patients to ensure robust findings.
Using rankings from surface under the cumulative ranking, Dupilumab had the highest efficacy, while GR1802 demonstrated superior safety.

Cite This Study

Zheng et al. (2025) studied this question.

synapsesocial.com/papers/68c1dd9b54b1d3bfb60fc20b https://doi.org/10.69854/jcq.2025.0016

View Full Paper

Ask AI

Bookmark

Implication

Systematic review evaluates the efficacy of biologic therapies for chronic rhinosinusitis with nasal polyps, indicating Dupilumab and Tezepelumab are most effective.

Biologic Agents in the Treatment of Severe Chronic Rhinosinusitis with Nasal Polyps in Adults: A Systematic Review and Meta-Analysis

Discussion

Member takes

Implication

Key Points

Cite This Study

Biologic Agents in the Treatment of Severe Chronic Rhinosinusitis with Nasal Polyps in Adults: A Systematic Review and Meta-Analysis

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider